1. S7A safety pharmacology studies for human pharmaceuticals. International Council for Harmonisation of technical requirements for pharmaceuticals for human use;Anonymous;Federal Register,2001
2. ICH S7B: The non-clinical evaluation of the potential fro delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. International Council for Harmonisation of technical requirements for Pharmaceuticals for Human use;Anonymous;Federal Register,2005
3. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Internal Council for Harmonisation of technical requirements for Pharmaceuticals for Human use;Anonymous;Federal Register,2005
4. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment;Blinova;Cell Reports,2018